Filing Details
- Accession Number:
- 0001127602-13-035070
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 18:14:28
- Reporting Period:
- 2013-12-16
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 18:14:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1520262 | Alkermes Plc. | ALKS | Pharmaceutical Preparations (2834) | 981007018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1376548 | Elliot Ehrich | 852 Winter St. Waltham MA 02451 | Svp, R&D & Cmo, Alkermes, Inc. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2013-12-16 | 23,731 | $15.95 | 40,310 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-16 | 6,269 | $15.95 | 46,579 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-16 | 15,000 | $14.13 | 61,579 | No | 4 | M | Direct | |
Ordinary Shares | Acquisiton | 2013-12-16 | 8,136 | $12.29 | 69,715 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-12-16 | 45,200 | $38.69 | 24,515 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2013-12-16 | 7,936 | $39.61 | 16,579 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2013-12-18 | 7,718 | $18.60 | 24,297 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2013-12-18 | 7,718 | $38.84 | 16,579 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2013-12-16 | 23,731 | $0.00 | 23,731 | $15.95 |
Ordinary Shares | Incentive Stock Option (Right to Buy) | Disposition | 2013-12-16 | 6,269 | $0.00 | 6,269 | $15.95 |
Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2013-12-16 | 15,000 | $0.00 | 15,000 | $14.13 |
Ordinary Shares | Employee Stock Option (Right to Buy) | Disposition | 2013-12-16 | 8,136 | $0.00 | 8,136 | $12.29 |
Ordinary Shares | Non Qualified Stock Option (Right to Buy) | Disposition | 2013-12-18 | 7,718 | $0.00 | 7,718 | $18.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-06-01 | No | 4 | M | Direct | |
0 | 2017-06-01 | No | 4 | M | Direct | |
0 | 2017-11-05 | No | 4 | M | Direct | |
0 | 2018-05-27 | No | 4 | M | Direct | |
1,748 | 2015-12-09 | No | 4 | M | Direct |
Footnotes
- This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.26 to $39.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.27 to $39.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.82 to $38.88. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- These options are fully vested in accordance with their terms.